IGF2BP3 and acute myeloid leukemia: We performed univariate Cox regression analysis of the expression levels of m6A RNA methylation regulators in the TCGA data set, and found that AML patients with high expression of IGF2BP3 ALKBH5 and IGF2BP2 had poor survival.